GAL and Alzheimer disease: Of consequence, Acetyl-cholinesterase (AChE) inhibitors (AChEI), including Donepezil (DON), Galantamine (GAL), and Rivastigmine (RIV) still represent the main pharmacological treatment in AD patients.